Drug Profile
SP 14037
Alternative Names: SP14037Latest Information Update: 12 Oct 2021
Price :
$50
*
At a glance
- Originator Spherium Biomed
- Class Neuroprotectants; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis
Most Recent Events
- 27 Apr 2018 Discontinued - Preclinical for Amyotrophic lateral sclerosis in Spain (Intraperitoneal) (Spherium Biomed pipeline, April 2018)
- 27 Apr 2018 Discontinued - Preclinical for Amyotrophic lateral sclerosis in Spain (SC) (Spherium Biomed pipeline, April 2018)